A recent surge in terminations of research grants by the National Institutes of Health (NIH) is severely disrupting the landscape of critical clinical research, affecting an estimated 1 in 30 trials and involving over 74,000 participants.
These unprecedented funding cuts, which began when President Trump took office in early 2025, raise serious concerns regarding data integrity, financial waste, and the ethical responsibilities owed to trial participants.
